You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil
- 2. CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
- 3. CytoDyn to File Accelerated Rolling Review with MHRA and Interim Order (IO) with Health Canada for COVID-19
- 4. STAT+: CytoDyn's wild weekend of data-mining study results ends in failure for its Covid treatment
- 5. Reirradiation by Nanoparticles and Hypofractionated Protontherapy of Relapses Tumors: Non-randomized Phase II Study.
- 6. Clinical Validation of Cervical Cancer Screening Methods
- 7. In France, there's no escape from Covid vaccine sceptics. What would Pasteur think?
- 8. Surgeons fear wave of lawsuits over delays to cancer treatment
- 9. Phase 1 cancer biotech Ikena Oncology files for a $100 million IPO
- 10. IPO for Oxford COVID-19 vaccine startup in peril
Last updated at 14:38 GMT
Hot News Makers
Health/Pharma Companies
-
25979.03
-
17950.48
-
17182.54
-
16025.98
-
15300.65
-
15014.65
-
13649.78
-
13222.78
-
12775.18
-
10070.70
Last updated at 14:10 GMT
© Copyright 2021 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK